Wilson & Boucher Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Buy |
53,338
+1,320
| +3% | +$91.1K | 2.57% | 8 |
|
|
2025
Q1 | $3.61M | Sell |
52,018
-2,620
| -5% | -$182K | 2.69% | 6 |
|
|
2024
Q4 | $4.7M | Sell |
54,638
-1,705
| -3% | -$147K | 3.33% | 5 |
|
|
2024
Q3 | $6.71M | Buy |
56,343
+155
| +0.3% | +$18.5K | 4.62% | 3 |
|
|
2024
Q2 | $8.02M | Buy |
56,188
+2,037
| +4% | +$291K | 6.15% | 2 |
|
|
2024
Q1 | $6.95M | Sell |
54,151
-2,470
| -4% | -$317K | 5.48% | 2 |
|
|
2023
Q4 | $5.86M | Buy |
56,621
+415
| +0.7% | +$42.9K | 4.93% | 3 |
|
|
2023
Q3 | $5.11M | Buy |
56,206
+640
| +1% | +$58.2K | 4.86% | 3 |
|
|
2023
Q2 | $4.5M | Buy |
55,566
+230
| +0.4% | +$18.6K | 4.05% | 3 |
|
|
2023
Q1 | $4.4M | Buy |
55,336
+1,326
| +2% | +$106K | 4.23% | 3 |
|
|
2022
Q4 | $3.65M | Buy |
54,010
+50
| +0.1% | +$3.38K | 3.75% | 4 |
|
|
2022
Q3 | $2.69M | Buy |
53,960
+1,000
| +2% | +$49.8K | 3.13% | 5 |
|
|
2022
Q2 | $2.95M | Sell |
52,960
-840
| -2% | -$46.8K | 3.24% | 5 |
|
|
2022
Q1 | $2.99M | Sell |
53,800
-1,630
| -3% | -$90.5K | 2.71% | 6 |
|
|
2021
Q4 | $3.1M | Buy |
+55,430
| New | +$3.1M | 2.8% | 6 |
|